
### [Orphanet:263440](http://www.orpha.net/ORDO/Orphanet_263440)
**Label:** Neuroacanthocytosis

**Subclasses:** [Orphanet:157850](http://www.orpha.net/ORDO/Orphanet_157850) (Pantothenate kinase-associated neurodegeneration), [Orphanet:2388](http://www.orpha.net/ORDO/Orphanet_2388) (Choreoacanthocytosis), [Orphanet:59306](http://www.orpha.net/ORDO/Orphanet_59306) (McLeod neuroacanthocytosis syndrome), [Orphanet:98934](http://www.orpha.net/ORDO/Orphanet_98934) (Huntington disease-like 2), 

**Corr. equiv. classes:** [OMIM:606438](http://purl.obolibrary.org/obo/OMIM_606438), [Orphanet:2388](http://www.orpha.net/ORDO/Orphanet_2388), [Orphanet:59306](http://www.orpha.net/ORDO/Orphanet_59306), [OMIM:300842](http://purl.obolibrary.org/obo/OMIM_300842), [Orphanet:157850](http://www.orpha.net/ORDO/Orphanet_157850), [Orphanet:98934](http://www.orpha.net/ORDO/Orphanet_98934), [OMIM:234200](http://purl.obolibrary.org/obo/OMIM_234200), [OMIM:200150](http://purl.obolibrary.org/obo/OMIM_200150), 

**Class expressions from DL-Learner:**

- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0031466](http://purl.obolibrary.org/obo/HP_0031466) (Impairment in personality functioning) 75.00%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) 75.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0031466](http://purl.obolibrary.org/obo/HP_0031466) (Impairment in personality functioning) 75.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 75.00%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 75.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 69.72%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 69.72%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 69.72%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 69.72%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0100852](http://purl.obolibrary.org/obo/HP_0100852) (Abnormal fear/anxiety-related behavior) 68.75%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0007367](http://purl.obolibrary.org/obo/HP_0007367) (Atrophy/Degeneration affecting the central nervous system) 68.75%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0004305](http://purl.obolibrary.org/obo/HP_0004305) (Involuntary movements) 68.75%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) 68.75%
- [HP:0001260](http://purl.obolibrary.org/obo/HP_0001260) (Dysarthria) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) 68.75%
- [HP:0000739](http://purl.obolibrary.org/obo/HP_0000739) (Anxiety) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) 68.75%


